NewsBenzingaFDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies FDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies Benzinga 2026.10.19 15:13 (GMT+0) Open on Benzinga Other news Bitcoin Treasury Financing Model Under Pressure, Strategy and Strive Turn to High-Yield Preferred Stock to Compete for Investors What to Expect From Fortive's Q3 2026 Earnings Report Anthropic faces FUD pressure: co-founder siblings' tens of millions in equity awards spark controversy Earnings Preview: What To Expect From Tyler Technologies' Report Delphi Digital: Speculation will be the theme of the next decade; recommends holding trading platforms rather than traded assets Zcash developer submits proposal for NU7 mainnet activation height, expected to take effect on November 5
Bitcoin Treasury Financing Model Under Pressure, Strategy and Strive Turn to High-Yield Preferred Stock to Compete for Investors
Anthropic faces FUD pressure: co-founder siblings' tens of millions in equity awards spark controversy
Delphi Digital: Speculation will be the theme of the next decade; recommends holding trading platforms rather than traded assets
Zcash developer submits proposal for NU7 mainnet activation height, expected to take effect on November 5
